Sign inJoin waitlistJoin the waitlist

MR

Merlin Robb

Deputy Director for Clinical Research, US Military HIV Research Program · National Capital Consortium

Credentials: · · ·

History

US Military HIV Research Program · National Capital Consortium
Present
National Capital Consortium
Present

Pediatric Infectious Diseases
1984–1987
Pediatrics
Madigan Army Medical Center
1981–1984
Baylor College of Medicine
1977–1981
1977 B.A. San Diego State University
1977

Research

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
New England Journal of Medicine · 2009 · 2,466 citations
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
New England Journal of Medicine · 2021 · 1,938 citations
Immune-correlates analysis of an HIV-1 vaccine efficacy trial
New England Journal of Medicine · 2012 · 1,590 citations

NM
Nelson Michael
236 papers
JK
Jerome Kim
114 papers
JA
Jintanat Ananworanich
67 papers
DB
Deborah Birx
60 papers
TC
Trevor Crowell
57 papers · 11 as a fellow
Julie Ake
50 papers
MM
Mary Marovich
37 papers
JM
John Mascola
28 papers
Barton Haynes
25 papers
Dan Barouch
22 papers
DC
Donn Colby
22 papers
VV
Victor Valcour
21 papers

Grants

The Military HIV Research Program (MHRP) Clinical Trial Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $10.8M · Henry m. Jackson Fdn for the Adv Mil/Med
2013–2027
Targeting HIV Reservoirs in Children with HIVIS DNA and MVA-CMDR Vaccines
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $5.7M · Henry m. Jackson Fdn for the Adv Mil/Med
2018–2026
The Latent HIV Reservoir in Early-Treated Thai Children
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $520K · Henry m. Jackson Fdn for the Adv Mil/Med
2014–2021
Determinants of Resilience in Youth with HIV Infection and Youth Affected by HIV
National Institute of Mental Health · R01
Contact PI · $461.9K · Henry m. Jackson Fdn for the Adv Mil/Med
2014–2020

Clinical trials

Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth
Study chair · Completed · Phase 1
Henry M. Jackson Foundation for the Advancement of Military Medicine
2022–2023
Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2016–2021
Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2015–2017
Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2012